We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNDX icon
1126
Syndax Pharmaceuticals
SNDX
$1.7B
$2K ﹤0.01%
+77
New +$1.6K
STRO icon
1127
Sutro Biopharma
STRO
$384M
$2K ﹤0.01%
+7
New +$1.16K
SUPN icon
1128
Supernus Pharmaceuticals
SUPN
$2.71B
$2K ﹤0.01%
99
-197
-67% -$4.24K
TBPH icon
1129
Theravance Biopharma
TBPH
$875M
$2K ﹤0.01%
120
-228
-66% -$4.09K
VNDA icon
1130
Vanda Pharmaceuticals
VNDA
$301M
$2K ﹤0.01%
120
-181
-60% -$2.18K
TVRD
1131
Tvardi Therapeutics
TVRD
$22.1M
$2K ﹤0.01%
3
-4
-57% -$2.1K
PETQ
1132
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
55
-81
-60% -$2.51K
IMGN
1133
DELISTED
Immunogen Inc
IMGN
$2K ﹤0.01%
384
-612
-61% -$3.57K
AMTI
1134
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$2K ﹤0.01%
+66
New +$2.09K
ICPT
1135
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2K ﹤0.01%
62
-123
-66% -$4.08K
TCRR
1136
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$2K ﹤0.01%
+63
New +$1.59K
PRVB
1137
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$2K ﹤0.01%
+106
New +$1.59K
ATNX
1138
DELISTED
Athenex, Inc. Common Stock
ATNX
$2K ﹤0.01%
9
-13
-59% -$3.2K
RDUS
1139
DELISTED
Radius Health, Inc.
RDUS
$2K ﹤0.01%
88
-173
-66% -$2.6K
EPZM
1140
DELISTED
Epizyme, Inc
EPZM
$2K ﹤0.01%
191
-380
-67% -$4.69K
LMNX
1141
DELISTED
Luminex Corp
LMNX
$2K ﹤0.01%
87
-167
-66% -$3.88K
ZGNX
1142
DELISTED
Zogenix, Inc.
ZGNX
$2K ﹤0.01%
105
-210
-67% -$4.29K
ABUS icon
1143
Arbutus Biopharma
ABUS
$845M
$1K ﹤0.01%
+160
New +$560
ACIU icon
1144
AC Immune
ACIU
$231M
$1K ﹤0.01%
158
-267
-63% -$1.36K
ADAP
1145
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
+256
New +$1.39K
AFMD
1146
DELISTED
Affimed
AFMD
$1K ﹤0.01%
19
-24
-56% -$1.13K
AKBA icon
1147
Akebia Therapeutics
AKBA
$338M
$1K ﹤0.01%
316
-489
-61% -$1.43K
ALT icon
1148
Altimmune
ALT
$580M
$1K ﹤0.01%
+62
New +$731
ANAB icon
1149
AnaptysBio
ANAB
$1.53B
$1K ﹤0.01%
60
-112
-65% -$2.72K
ANIP icon
1150
ANI Pharmaceuticals
ANIP
$1.84B
$1K ﹤0.01%
27
-41
-60% -$1.17K

Similar funds

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.